column
Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in KRAS-mutant advanced non-small cell lung cancer
XIE Jianlian, LI Jinyu, LIU Zhefeng
2020, 41(6): 588-592. DOI: 10.3969/j.issn.2095-5227.2020.06.010
Abstract PDF
Expressions of PD-1/PD-L1 in tissues of Bowen's disease and cutaneous squamous cell carcinoma
ZHI Jia, LI Dongning, ZHENG Song, YANG Yang, ZHAO Fengmei
2020, 41(6): 628-633. DOI: 10.3969/j.issn.2095-5227.2020.06.018
Abstract PDF